@article{RomboWeiherSchmidtWolf2016,
  author    = {Roman Rombo and Hans Weiher and Ingo G. H. Schmidt-Wolf},
  title     = {Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells},
  series   = {GMS German Medical Science},
  volume    = {14},
  publisher = {German Medical Science},
  issn      = {1612-3174},
  doi       = {10.3205/000231},
  url       = {https://nbn-resolving.org/urn:nbn:de:hbz:1044-opus-24148},
  year      = {2016},
  abstract  = {We examined the cytotoxic effects of chaetocin on clear cell renal cell carcinoma (ccRCC) cells and the possibility to combine the effects of chaetocin with the effects of cytokine-induced killer cells (CIK) assayed by MTT assay and FACS analysis. Chaetocin is a thiodioxopiperazine produced by fungi belonging to the chaetomiaceae family. In 2007, it was first reported that chaetocin shows potent and selective ex vivo anti-cancer activity by inducing reactive oxygen species. CIK cells are generated from CD3+/CD56- T lymphocytes with double negative CD4-/CD8- phenotype that are isolated from human blood. The addition of distinct interleukins and antibodies results in the generation of CIK cells that are able to specifically target and destroy renal carcinoma cells. The results of this research state that the anti-ccRCC activity of chaetocin is weak and does not show a high grade of selectivity on clear cell renal cell carcinoma cells. Although the CIK cells show a high grade of selective anti-ccRCC activity, this effect could not be improved by the addition of chaetocin. So chaetocin seems to be no suitable agent for specific targeting ccRCC cells or for the combination therapy with CIK cells in renal cancer.},
  language  = {en}
}